Skip to main content
. 2022 Oct 13;10:1005098. doi: 10.3389/fped.2022.1005098

Table 5.

Dabigatran etexilate dosing (modified from dabigatran etexilate package insert).

Dosing
Treatment dosing (after completion of 5 days of parenteral treatment Age Weight (kg) Age (months) Dose (mg)
<2 years 3–3.9 3–5.9 30 BID
4–4.9 3–9.9 40 BID
5–6.9 3–4.9 40 BID
5–23.9 50 BID
7–8.9 3–3.9 50 BID
4–8.9 60 BID
9–23.9 70 BID
9–10.9 5–5.9 60 BID
6–10.9 80 BID
11–23.9 90 BID
11–12.9 8–17.9 100 BID
18–23.9 110 BID
13–15.9 10–10.9 100 BID
11–23.9 140 BID
16–20.9 12–23.9 140 BID
21–25.9 18–23.9 180 BID
Age Weight (kg) Dose (mg)
2–11.9 years 7–8.9 70 BID
9–10.9 90 BID
11–12.9 110 BID
13–15.9 140 BID
16–20.9 170 BID
21–40.9 220 BID
≥41 260 BID
Thromboprophylaxis dosing Not available

BID, twice a day.